Even though several GWAS have reproducibly implicated the association of Cav-1 polymorphisms with POAG and other ocular hypertension metrics [3, 36-38], the limitations of GWAS should be considered in all future studies to enhance the statistical power enabling the actual and not misleading associations [39, 40]. This evidence concerns the gene CAV1 and ocular hypertension.